4.7 Article

The secRNome of Listeria monocytogenes Harbors Small Noncoding RNAs That Are Potent Inducers of Beta Interferon

Journal

MBIO
Volume 10, Issue 5, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.01223-19

Keywords

Listeria monocytogenes; type I IFN; secreted RNA

Categories

Funding

  1. Transregional Collaborative Research Centre SFB TR 84 (Innate Immunity of the Lung) [TP A4]
  2. Bundesministerium fur Bildung und Forschung (Infect-ERA PROANTILIS)
  3. German Research Foundation (DFG) [SFB 1021]
  4. DFG [SPP 1596, 387 KFO 309]
  5. German Center for Infection Research (DZIF), Partner Site Giessen, Giessen, Germany (TTU Emerging Infections)
  6. University of Giessen, Giessen, Germany

Ask authors/readers for more resources

Cellular sensing of bacterial RNA is increasingly recognized as a determinant of host-pathogen interactions. The intracellular pathogen Listeria monocytogenes induces high levels of type I interferons (alpha/beta interferons [IFN-alpha/beta]) to create a growth-permissive microenvironment during infection. We previously demonstrated that RNAs secreted by L. monocytogenes (comprising the secRNome) are potent inducers of IFN-beta. We determined the composition and diversity of the members of the secRNome and found that they are uniquely enriched for noncoding small RNAs (sRNAs). Testing of individual sRNAs for their ability to induce IFN revealed several sRNAs with this property. We examined ril32, an intracellularly expressed sRNA that is highly conserved for the species L. monocytogenes and that was the most potent inducer of IFN-beta expression of all the sRNAs tested in this study, in more detail. The rli32-induced IFN-beta response is RIG-I (retinoic acid inducible gene I) dependent, and cells primed with rli32 inhibit influenza virus replication. We determined the rli32 motif required for IFN induction. rli32 overproduction promotes intracellular bacterial growth, and a mutant lacking rli32 is restricted for intracellular growth in macrophages. rli32-overproducing bacteria are resistant to H2O2 and exhibit both increased catalase activity and changes in the cell envelope. Comparative transcriptome sequencing (RNA-Seq) analysis indicated that ril32 regulates expression of the lhrC locus, previously shown to be involved in cell envelope stress. Inhibition of IFN-beta signaling by ruxolitinib reduced rli32-dependent intracellular bacterial growth, indicating a link between induction of the interferon system and bacterial physiology. rli32 is, to the best of our knowledge, the first secreted individual bacterial sRNA known to trigger the induction of the type I IFN response. IMPORTANCE Interferons are potent and broadly acting cytokines that stimulate cellular responses to nucleic acids of unusual structures or locations. While protective when induced following viral infections, the induction of interferons is detrimental to the host during L. monocytogenes infection. Here, we identify specific sRNAs, secreted by the bacterium, with the capacity to induce type I IFN. Further analysis of the most potent sRNA, rli32, links the ability to induce RIG-I-dependent induction of the type I IFN response to the intracellular growth properties of the bacterium. Our findings emphasize the significance of released RNA for Listeria infection and shed light on a compartmental strategy used by an intracellular pathogen to modulate host responses to its advantage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Newly synthesized series of oxoindole-oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies

Rana M. El-Masry, Ahmed A. Al-Karmalawy, Radwan Alnajjar, Sara H. Mahmoud, Ahmed Mostafa, Hanan H. Kadry, Sahar M. Abou-Seri, Azza T. Taher

Summary: In this study, a series of anti-SARS-CoV-2 agents were designed and synthesized, and their binding affinities and virus-inhibitory concentrations were evaluated. Compounds IVe and IVg showed high activity and have the potential to be developed as broad-spectrum anti-SARS-CoV-2 agents.

NEW JOURNAL OF CHEMISTRY (2022)

Article Microbiology

Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection

Aaqib Sohail, Azeem A. Iqbal, Nishika Sahini, Fangfang Chen, Mohamed Tantawy, Syed F. H. Waqas, Moritz Winterhoff, Thomas Ebensen, Kristin Schultz, Robert Geffers, Klaus Schughart, Matthias Preusse, Mahmoud Shehata, Heike Baehre, Marina C. Pils, Carlos A. Guzman, Ahmed Mostafa, Stephan Pleschka, Christine Falk, Alessandro Michelucci, Frank Pessler

Summary: Excessive inflammation caused by viral infections, including influenza, can lead to severe illness and death. Itaconate, a metabolite that modulates the immune response, has been found to have antiviral effects and can redirect inflammatory responses. In this study, researchers investigated the effects of itaconate and its variants on the host's response to influenza A virus. They found that treatment with itaconate and its variants reduced viral replication and inflammation in both mice and human cells. The compounds also modulated interferon responses and reduced the release of pro-inflammatory chemokines. Overall, these findings suggest that itaconates could be used as immunomodulatory and antiviral interventions for influenza virus infection.

PLOS PATHOGENS (2022)

Article Chemistry, Medicinal

Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2

Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, Sameh S. M. Soliman, Bahgat Fayed

Summary: In this study, flavonoids were systematically evaluated for their potential antiviral activity against SARS-CoV-2. Among the tested compounds, silibinin showed promising selectivity index and high inhibition activity against SARS-CoV-2 key proteins. It also demonstrated safety in human mammalian cells and strong virucidal activity. Molecular docking analysis revealed the excellent binding affinity of silibinin to S protein and RdRP. Overall, silibinin, an FDA-approved drug, can effectively interfere with SARS-CoV-2 entry and replication through multi-targeting activity.

PHYTOTHERAPY RESEARCH (2022)

Article Biochemistry & Molecular Biology

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease

Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, Noura M. Abo Shama, Eman Y. Santali, Bahaa Elgendy, Ahmed A. Al-Karmalawy

Summary: In this study, a series of new derivatives were designed and synthesized based on the structural optimization principle of the SARS-CoV Mpro co-crystallized WR1 inhibitor. Compound 3b showed the most promising anti-SARS-CoV-2 activity, and molecular dynamics simulations indicated its stability inside the binding pocket.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

Article Virology

Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone

Georgios-Dimitrios Panagiotidis, Christin Mueller, Marco Binder, Friedemann Weber

Summary: The FDA-approved drug paliperidone has been found to inhibit the replication of influenza A virus by interfering with the binding of the polymerase subunit PB2 to the nucleoprotein NP. However, its effects are transient and limited to specific virus strains.

ARCHIVES OF VIROLOGY (2023)

Article Chemistry, Medicinal

Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors

Santo Previti, Roberta Ettari, Elsa Calcaterra, Salvatore Di Maro, Stefan J. Hammerschmidt, Christin Mueller, John Ziebuhr, Tanja Schirmeister, Sandro Cosconati, Maria Zappala

Summary: Despite progress in the development of vaccines and antivirals, the fight against SARS-CoV-2 and COVID-19 continues. Researchers have identified compounds that target the SARS-CoV-2 main protease, an essential viral enzyme, and have developed inhibitors with promising antiviral activity. These inhibitors also showed inhibitory effects on hCatL, a protein involved in viral entry into host cells. Some of these compounds demonstrated significant activity against SARS-CoV-2 in cell culture.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Synthesis and Molecular Docking Study of Novel Pyrimidine Derivatives against COVID-19

Zahra M. Alamshany, Reham R. Khattab, Nasser A. Hassan, Ahmed A. El-Sayed, Mohamed A. Tantawy, Ahmed Mostafa, Allam A. Hassan

Summary: A novel series of pyrido[2,3-d]pyrimidines, pyrido[3,2-e][1,3,4]triazolo, and tetrazolo[1,5-c]pyrimidines were synthesized and their structures were elucidated. Molecular docking analysis revealed that compounds 7c, 7d, and 7e exhibited promising antiviral activity against SARS-CoV-2 main protease M(pro) with lower IC50 values compared to the commonly used protease inhibitor Lopinavir. The in silico and in vitro results were consistent.

MOLECULES (2023)

Letter Multidisciplinary Sciences

Reply to: The stress-inducible ER chaperone GRP78/BiP is upregulated during SARS-CoV-2 infection and acts as a pro-viral protein

Mohammed Samer Shaban, Christin Mueller, Christin Mayr-Buro, Hendrik Weiser, M. Lienhard Schmitz, John Ziebuhr, Michael Kracht

NATURE COMMUNICATIONS (2022)

Article Microbiology

Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses

David Scheibner, Ahmed H. Salaheldin, Ola Bagato, Luca M. Zaeck, Ahmed Mostafa, Ulrike Blohm, Christin Mueller, Ahmed F. Eweas, Kati Franzke, Axel Karger, Alexander Schaefer, Marcel Gischke, Donata Hoffmann, Solene Lerolle, Xuguang Li, Hatem S. Abd El-Hamid, Jutta Veits, Angele Breithaupt, Geert-Jan Boons, Mikhail Matrosovich, Stefan Finke, Stephan Pleschka, Thomas C. Mettenleiter, Robert P. de Vries, Elsayed M. Abdelwhab

Summary: Mutations in the neuraminidase (NA) of human H5N1 viruses play different roles in infection of mammals without affecting virulence or transmission in chickens. This study is important to understand the genetic determinants for replication of avian influenza viruses in mammals and should assist in the prediction of avian influenza viruses with zoonotic potential.

PLOS PATHOGENS (2023)

Article Microbiology

Differential Impact of Specific Amino Acid Residues on the Characteristics of Avian Influenza Viruses in Mammalian Systems

Dayly Mashaal, Sara H. Mahmoud, Christin Mueller, Noura M. Abo Shama, Amal Abo Kamer, Ahmed A. Abdelaziz, Mohamed A. Ali, Stephan Pleschka, Ahmed Mostafa

Summary: Avian influenza virus (AIV) H9N2 is endemic in birds in the Middle East, particularly in Egypt, with multiple cases of human infections. Adaptive amino acid mutations in the viral polymerase, specifically in the PB2 gene, can enhance cross-species transmission of the virus. The presence of 591K in the PB2 gene of H9N2 strains in Egypt significantly increases the replication efficiency and polymerase activity of H5N1 variants in mammalian cells.

PATHOGENS (2022)

Article Multidisciplinary Sciences

Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities

Bahaa A. Hemdan, Ahmed Mostafa, Marwa M. Elbatanony, Amal M. El-Feky, Tsvetelina Paunova-Krasteva, Stoyanka Stoitsova, Mohamed Azab El-Liethy, Gamila E. El-Taweel, Mobarak Abu Mraheil

Summary: The leaves of Azadirachta indica L. and Melia azedarach L. have medicinal benefits and exhibit antiviral and antibacterial activities. They showed robust anti-SARS-CoV-2 activity and exhibited broad-spectrum medicinal value.

PLOS ONE (2023)

Article Microbiology

Genome Analysis of Pseudomonas aeruginosa Strains from Chronically Infected Patients with High Levels of Persister Formation

Amr A. Baiomy, Fathy E. Serry, Ashraf A. Kadry, Galal Yahya, Swapnil Doijad, Ahmed Mostafa, Mobarak Abu Mraheil, Amira M. El-Ganiny

Summary: This study conducted genomic analyses of Pseudomonas aeruginosa persister isolates from chronic human infections, revealing their low metabolic rates, multidrug tolerance, and strong biofilm-forming ability. Whole genome sequencing and phylogenetic analysis showed that these persister isolates belong to a distinct clade with a smaller genome size.

PATHOGENS (2023)

Review Immunology

Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution

Ahlam Alasiri, Raya Soltane, Akram Hegazy, Ahmed Magdy Khalil, Sara H. Mahmoud, Ahmed A. Khalil, Luis Martinez-Sobrido, Ahmed Mostafa

Summary: Despite being widespread in wild birds and domestic poultry, human infections with highly pathogenic avian influenza H5Nx viruses have been limited since 1996. Few countries use vaccination as a control strategy, while most rely on culling infected flocks. China and Egypt are the major sites where vaccination has been employed, particularly for clade 2.3.4.4b H5N1 viruses. However, improper implementation of control strategies in Egypt has resulted in continuous outbreaks and virus evolution. Comprehensive surveillance in endemic areas is crucial to understand the public health risk of newly emerging immune-evasive or drug-resistant H5Nx variants.

VACCINES (2023)

Article Microbiology

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E

Yassmin Moatasim, Omnia Kutkat, Ahmed M. Osman, Mokhtar R. Gomaa, Faten Okda, Mohamed El Sayes, Mina Nabil Kamel, Mohamed Gaballah, Ahmed Mostafa, Rabeh El-Shesheny, Ghazi Kayali, Mohamed A. Ali, Ahmed Kandeil

Summary: The study found potential broad-spectrum inhibitory effects of Hydroxocobalamin and Methylcobalamin against three coronaviruses. Cyanocobalamin selectively affects SARS-CoV-2, while Methylcobalamin shows higher inhibition on SARS-CoV-2 compared to Hydroxocobalamin and Cyanocobalamin. These vitamins may have significant binding affinity to viral-specific cell receptors and proteins, suggesting potential benefits for coronavirus-infected patients.

MICROORGANISMS (2023)

Article Biotechnology & Applied Microbiology

Dual action of epigallocatechin-3-gallate in virus-induced cell Injury

Ahmed Mostafa, Gomaa Mostafa-Hedeab, Hany Abdelfattah Elhady, Esraa Ahmed Mohamed, Abozer Y. Eledrdery, Sager Holyl Alruwaili, Ahmed Mohamed Al-Abd, Abdou Kamal Allayeh

Summary: EGCG, the most abundant polyphenol in green tea, has been shown to have significant antiviral activity against SARS-CoV-2 and HSV-2, as well as wound healing properties. It could potentially be a promising option for slowing down the course of acute cellular damage induced by systemic or topical viral infections.

JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2023)

No Data Available